Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Havrix Co-administered with Infanrix and ActHIB in Healthy Children
NCT00197236Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 2003
- Primary completion
- Dec 2007
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Hepatitis A virus vaccine in hepatitis A (HAV), sponsored by GSK. Started Nov 2003; status: completed.
02
Drugs
Hepatitis A virus vaccine
03
Conditions
hepatitis A (HAV)
Beyond the preview
Go deeper on NCT00197236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00197236.